+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmacyclics llc - logo

Pharmacyclics LLC focuses on developing novel therapies for the treatment of cancer and immune-mediated diseases in the United States. The company markets IMBRUVICA, a single-agent therapy used for the treatment of patients with chronic lymphocytic leukemia, mantle cell lymphoma and waldenström's macroglobulinemia. It also has several product candidates in clinical development. The company was founded in 1991 and is headquartered in Sunnyvale, California.

From
From
Mantle Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Mantle Cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Diffuse Large B-cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Diffuse Large B-cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
From
Hematological Malignancies Market - Forecast (2022 - 2027) - Product Thumbnail Image

Hematological Malignancies Market - Forecast (2022 - 2027)

  • Report
  • February 2022
  • 100 Pages
  • Global
From
From
Blood Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Blood Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Factor VIIa Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Factor VIIa Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Orphan Drugs Market Report 2023-2033 - Product Thumbnail Image

Orphan Drugs Market Report 2023-2033

  • Report
  • October 2023
  • 258 Pages
  • Global
From
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Loading Indicator